Overview of safety of non-biologic and biologic DMARDs - Ruderman, E. M. (Rheumatology (Oxford, England), 2012)
Keywords: Antirheumatic Agents - adverse effects; Antirheumatic Agents - therapeutic use; Arthritis, Rheumatoid - drug therapy; Biological Products - adverse effects; Biological Products - therapeutic use; Clinical trials; Humans; Mycobacterium; Opportunistic Infections - epidemiology; Registries; Risk Factors; Treatment Outcome